Faeth Therapeutics FTH
NASDAQ FTH
$17.08 -3.02 (-15.02%)
At close: Oct 23, 2026 · 4:00 PM EDT

Faeth Therapeutics (FTH) Non Operating Investment Income (2021 - 2025)

Updated

Faeth Therapeutics (FTH) recorded Non Operating Investment Income of -$1,000 in Q3 2025.

Analysis

Faeth Therapeutics (FTH) Non Operating Investment Income (2021 - 2025) Analysis & Trends

On a TTM basis, Faeth Therapeutics' Non Operating Investment Income came in at -$21,000 as of Sep 30, 2025; for FY2023, it came in at -$302,000.

  • Across earlier years, Non Operating Investment Income came in at -$9,000 in FY2021.
  • Quarterly Non Operating Investment Income has ranged from -$191,000 in Q2 2023 to $20,000 in Q1 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Faeth Therapeutics 98.59 Mn -336.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -1,000.00
Jun 30, 2025 -40,000.00
Mar 31, 2025 20,000.00
Sep 30, 2023 -6,000.00
Jun 30, 2023 -191,000.00
Mar 31, 2023 -105,000.00
Dec 31, 2021 19,000.00
Jun 30, 2021 -28,000.00
API Access

Faeth Therapeutics Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=FTH&period=max&api_key=YOUR_API_KEY